Friday, September 18, 2020
wellness India Expo
Home Tags VPM1002

Tag: VPM1002

COVID-19: Supported by DBT, Serum Institute’s rBCG vaccine efficacy trial enrolls...

Serum Institute of India has been supported under the Department of Biotechnology’s National Biopharma Mission for conduct of a multisite randomized double-blinded placebo-controlled phase III clinical trial of a recombinant BCG vaccine candidate, VPM1002.............................

New efficacious vaccine to fight TB on the horizon

The scientists of National Institute for Research in Tuberculosis (NIRT), Chennai are working on a vaccine based on fresh approach and aims at preventing TB in adults............